EUVIMEDOpdag EUVIMED
Systematische ÜbersichtMetaanalyseOpen access · CC BY-NC 4.0

Prognostic Benefit of the Target Vessel in Revascularization of Chronic Total Occluded Coronary Arteries: A Systematic Review and Meta‐Analysis

Emil Skov iD, Emilie Kjær Hansen, Lone Juul-Hune Mogensen, Evald Høj Christiansen iD, Emil Nielsen Holck iD

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.70063 ↗

At a glance

Systematische Übersicht in Catheterization and Cardiovascular Interventions, 2025. Written by Emil Skov and 4 co-authors. Institution: Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark. Major MEDLINE topics: Coronary Occlusion, Percutaneous Coronary Intervention. 47 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Previous data have implied that percutaneous coronary intervention (PCI) of chronic total occlusions (CTO) is dependent on target vessel. This systematic review and meta‐analysis aimed to investigate if the benefit of CTO revascularization with PCI is dependent on the target vessel.

Methods

A comprehensive search of multiple databases was conducted to identify studies investigating CTO patients undergoing PCI in the left anterior descending artery (LAD), right coronary artery (RCA), or left circumflex artery (LCX). Outcomes for patients with successful CTO PCI were compared with those who did not undergo PCI stratified on target vessel. The primary outcome was all‐cause mortality, while secondary outcomes included major adverse cardiac events (MACE) and cardiac death (CD).

Results

Twenty observational studies were included after screening of 3053 studies. Successful CTO PCI was associated with a lower risk of all‐cause mortality for LAD (Hazard ratio [HR]: 0.51 [0.42, 0.62], p < 0.05, I 2 = 0%) and LCX (HR: 0.63 [0.41, 0.97], p < 0.05, I 2 = 40%) than no revascularization. The risk of MACE was only signficantly reduced after successful CTO PCI for LAD lesions (HR: 0.55 [0.47, 0.64], p < 0.05, I ² = 0%), but not for LCX (HR: 0.52 [0.10, 2.62], p = 0.43, I ² = 73%) or RCA (HR: 0.65 [0.19, 2.28], p = 0.50, I ² = 83%).

Conclusions

Successful CTO PCI in the LAD was consistently associated with lower all‐cause mortality, MACE, and CD compared to non‐revascularization, while results were variable for RCA and LCX. These findings emphasize the need for further randomized trials to clarify prognostic differences based on the target vessel.

Subjects

MeSH terms (MEDLINE)

Coronary OcclusionPercutaneous Coronary InterventionHumansChronic DiseaseTreatment OutcomeRisk FactorsRisk AssessmentMaleFemaleAgedMiddle AgedTime FactorsObservational Studies as Topic

Author keywords

chronic total occlusioncoronary artery diseasemeta‐analysispercutaneous coronary intervention

Authors and institutions

  • Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

ORCID profiles: Emil Skov, Evald Høj Christiansen, Emil Nielsen Holck

Cite

APA

Skov, E., Hansen, E. K., Mogensen, L. J., Christiansen, E. H., & Holck, E. N. (2025). Prognostic Benefit of the Target Vessel in Revascularization of Chronic Total Occluded Coronary Arteries: A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70063

Vancouver

Skov E, Hansen EK, Mogensen LJ, Christiansen EH, Holck EN. Prognostic Benefit of the Target Vessel in Revascularization of Chronic Total Occluded Coronary Arteries: A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70063

BibTeX
@article{Skov2025,
  author = {Skov, Emil and Hansen, Emilie Kjær and Mogensen, Lone Juul-Hune and Christiansen, Evald Høj and Holck, Emil Nielsen},
  title = {Prognostic Benefit of the Target Vessel in Revascularization of Chronic Total Occluded Coronary Arteries: A Systematic Review and Meta‐Analysis},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.70063}
}
Start for free →